$AIMD Nasdaq Alert!! Ainos Secures Taiwan Inventio
Post# of 8582
This patent marks a major leap in Ainos' antiviral research, contributing to global efforts against coronavirus infections
SAN DIEGO, CA / ACCESSWIRE / September 3, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos" or the "Company" , an innovative healthcare company focused on advanced AI-driven point-of-care testing (POCT) and low-dose interferon therapeutics, is pleased to announce that its groundbreaking VELDONA® formulation has been granted an invention patent in Taiwan and has filed for global patent protection under the Patent Cooperation Treaty (PCT). This patent represents a significant milestone in the treatment and prevention of coronavirus infections.
https://finance.yahoo.com/news/ainos-secures-...00316.html